csirt@kutim:~/threat-intel/cve/CVE-2026-19418

Katalog CVE

CVSS 7.3 · High EPSS 0,24%

Kerentanan Origin Validation Error. Skor CVSS 4.0 7.3 (High) menurut CNA.

Deskripsi (NVD)

The referrer enforcement introduced with TYPO3-CORE-SA-2020-006 (CVE-2020-11069) became ineffective in TYPO3 v13.0, where TYPO3 CMS started serving the backend and Install Tool applications from the site's main entry script instead of the dedicated typo3/ directory. Whether a request originated from the backend or Install Tool itself was determined by comparing the referrer against the directory of the entry script, which since then is the site root. As a consequence, requests originating from any script running on one of the TYPO3 instance's own domains, such as a frontend page, were accepted by backend routes and Install Tool endpoints. Attackers able to execute JavaScript on one of those domains, for instance by exploiting a cross-site scripting vulnerability, could invoke these endpoints via Fetch/XHR with the privileges of an authenticated victim's user session. This issue affects TYPO3 CMS versions 13.0.0-13.4.33 and 14.0.0-14.3.5.

Rincian

Terbit di NVD
11 Agustus 2026
Terakhir diubah
26 Agustus 2026
Status NVD
Deferred
CVSS 4.0
7.3 (High), sumber CNA
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-346: Origin Validation Error
CWE-352: Cross-Site Request Forgery (CSRF)
EPSS (30 hari)
0,24% peluang dieksploitasi; lebih tinggi dari 14,2% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.